Redmile Group as of June 30, 2020
Portfolio Holdings for Redmile Group
Redmile Group holds 80 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 8.0 | $433M | 13M | 34.31 | |
| Amicus Therapeutics (FOLD) | 6.9 | $376M | 25M | 15.08 | |
| Deciphera Pharmaceuticals | 5.5 | $297M | 5.0M | 59.72 | |
| Adc Therapeutics Sa SHS (ADCT) | 4.8 | $259M | 5.5M | 46.81 | |
| Argenx Se Sponsored Adr (ARGX) | 4.3 | $233M | 1.0M | 225.23 | |
| Igm Biosciences (IGMS) | 4.2 | $230M | 3.1M | 73.00 | |
| Biontech Se Sponsored Ads (BNTX) | 3.8 | $205M | 3.1M | 66.74 | |
| Allakos | 3.5 | $188M | 2.6M | 71.86 | |
| Principia Biopharma | 3.0 | $162M | 2.7M | 59.79 | |
| Momenta Pharmaceuticals | 2.9 | $157M | 4.7M | 33.27 | |
| Epizyme | 2.5 | $136M | 8.5M | 16.06 | |
| Immunomedics | 2.3 | $124M | 3.5M | 35.44 | |
| Pliant Therapeutics (PLRX) | 2.0 | $111M | 3.4M | 32.46 | |
| 1life Healthcare | 2.0 | $109M | 3.0M | 36.32 | |
| Atara Biotherapeutics | 1.8 | $100M | 6.8M | 14.57 | |
| Beam Therapeutics (BEAM) | 1.7 | $94M | 3.4M | 28.00 | |
| Cigna Corp (CI) | 1.7 | $91M | 486k | 187.65 | |
| Aprea Therapeutics | 1.6 | $88M | 2.3M | 38.78 | |
| Regenxbio Inc equity us cm (RGNX) | 1.5 | $82M | 2.2M | 36.83 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $80M | 1.7M | 48.02 | |
| Replimune Group (REPL) | 1.4 | $77M | 3.1M | 24.85 | |
| Repare Therapeutics Ord (RPTX) | 1.4 | $74M | 2.4M | 31.02 | |
| GenMark Diagnostics | 1.3 | $72M | 4.9M | 14.71 | |
| Neoleukin Therapeutics | 1.2 | $67M | 4.0M | 16.60 | |
| Hill-Rom Holdings | 1.2 | $64M | 585k | 109.78 | |
| Sanofi Sponsored Adr (SNY) | 1.2 | $63M | 1.2M | 51.05 | |
| Stoke Therapeutics (STOK) | 1.1 | $60M | 2.5M | 23.83 | |
| Nevro (NVRO) | 1.1 | $60M | 498k | 119.47 | |
| Krystal Biotech (KRYS) | 1.1 | $58M | 1.4M | 41.42 | |
| Tricida | 1.1 | $58M | 2.1M | 27.48 | |
| Uniqure Nv SHS (QURE) | 1.0 | $56M | 1.2M | 45.06 | |
| ImmunoGen | 1.0 | $55M | 12M | 4.60 | |
| Cryoport Com Par $0.001 (CYRX) | 1.0 | $55M | 1.8M | 30.25 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $52M | 2.9M | 18.21 | |
| Ppd | 1.0 | $52M | 1.9M | 26.80 | |
| Amedisys (AMED) | 0.8 | $45M | 226k | 198.54 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.8 | $45M | 5.1M | 8.87 | |
| Biogen Idec (BIIB) | 0.8 | $43M | 162k | 267.55 | |
| Axonics Modulation Technolog (AXNX) | 0.8 | $42M | 1.2M | 35.11 | |
| Merck & Co (MRK) | 0.7 | $41M | 524k | 77.33 | |
| Dex (DXCM) | 0.7 | $39M | 97k | 405.40 | |
| Novartis Sponsored Adr (NVS) | 0.7 | $38M | 440k | 87.34 | |
| ICU Medical, Incorporated (ICUI) | 0.7 | $37M | 201k | 184.31 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.7 | $36M | 1.1M | 33.89 | |
| Boston Scientific Corporation (BSX) | 0.6 | $32M | 897k | 35.11 | |
| UnitedHealth (UNH) | 0.6 | $31M | 104k | 294.95 | |
| Catalent | 0.6 | $30M | 413k | 73.30 | |
| Luminex Corporation | 0.6 | $30M | 918k | 32.53 | |
| Eidos Therapeutics | 0.5 | $28M | 594k | 47.67 | |
| Zymeworks | 0.5 | $28M | 784k | 36.07 | |
| Pra Health Sciences | 0.5 | $27M | 279k | 97.29 | |
| Tcr2 Therapeutics Inc cs | 0.5 | $27M | 1.8M | 15.36 | |
| Odonate Therapeutics Ord | 0.5 | $27M | 633k | 42.34 | |
| Twist Bioscience Corp (TWST) | 0.5 | $27M | 589k | 45.30 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $26M | 2.0M | 13.00 | |
| Ardelyx (ARDX) | 0.4 | $24M | 3.5M | 6.92 | |
| Guardant Health (GH) | 0.4 | $24M | 298k | 81.13 | |
| Hookipa Pharma Inc equity | 0.4 | $22M | 1.9M | 11.62 | |
| Atreca Cl A Com (BCEL) | 0.4 | $21M | 992k | 21.28 | |
| Gritstone Oncology Ord (GRTSQ) | 0.4 | $20M | 3.1M | 6.64 | |
| Cabaletta Bio (CABA) | 0.3 | $16M | 1.4M | 11.14 | |
| Immunovant (IMVT) | 0.3 | $15M | 600k | 24.35 | |
| Stereotaxis Com New (STXS) | 0.3 | $14M | 3.1M | 4.46 | |
| Invitae (NVTAQ) | 0.2 | $13M | 431k | 30.29 | |
| Selectquote Ord (SLQT) | 0.2 | $13M | 497k | 25.33 | |
| Itamar Med Sponsored Ads | 0.2 | $12M | 625k | 18.60 | |
| Akero Therapeutics (AKRO) | 0.2 | $9.8M | 392k | 24.92 | |
| Royalty Pharma Shs Cl A (RPRX) | 0.2 | $9.7M | 200k | 48.55 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.2 | $8.8M | 2.5M | 3.58 | |
| Profound Med Corp Com New (PROF) | 0.1 | $6.8M | 400k | 16.94 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $6.7M | 667k | 10.03 | |
| Xeris Pharmaceuticals | 0.1 | $6.4M | 2.4M | 2.66 | |
| Cymabay Therapeutics | 0.1 | $5.8M | 1.7M | 3.49 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $4.3M | 415k | 10.41 | |
| Burning Rock Biotech Sponsored Ads | 0.1 | $3.6M | 134k | 27.01 | |
| Syros Pharmaceuticals | 0.0 | $2.3M | 212k | 10.66 | |
| Vapotherm | 0.0 | $1.0M | 25k | 41.00 | |
| Ovid Therapeutics (OVID) | 0.0 | $899k | 122k | 7.37 | |
| Endologix Com New | 0.0 | $63k | 79k | 0.80 | |
| Castlight Health CL B | 0.0 | $8.0k | 10k | 0.78 |